Iluvien Implantation for Uveitis and Uveitic Macular Edema

Ashvini K. ReddyJohns Hopkins University, Wilmer Eye Institute, Baltimore, Maryland, USACorrespondence[email protected]

, MD,

Bryn M. BurkholderJohns Hopkins University, Wilmer Eye Institute, Baltimore, Maryland, USA

, MD,

Irfan R. KhanJohns Hopkins University, Wilmer Eye Institute, Baltimore, Maryland, USA

, MD &

Jennifer E. ThorneJohns Hopkins University, Wilmer Eye Institute, Baltimore, Maryland, USA

, MD, PhD

REFERENCES

Park UC, Park JH, Yu HG. Long-term outcome of intravitreal triamcinolone acetonide injection for the treatment of uveitis attacks in Behçet disease. Ocul Immunol Inflamm. 2014;22:27–33.
PubMed Web of Science ®Google Scholar
Zarranz-Ventura J, Carreño E, Johnston RL, et al. Multicenter study of intravitreal dexamethasone implant in noninfectious uveitis: indications, outcomes, and reinjection frequency. Am J Ophthalmol. 2014;158:1136–1145.
PubMed Web of Science ®Google Scholar
Kempen JH, Altaweel MM, Holbrook JT, et al.; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. Ophthalmology. 2011;118:1916–1926.
PubMed Web of Science ®Google Scholar
Campochiaro PA, Hafiz G, Shah SM, et al.; Famous Study Group. Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert. Ophthalmology. 2010;117:1393–1399.
PubMed Web of Science ®Google Scholar
Jedynak B, pSivida Corp. pSivida’s Medidur™ meets primary efficacy endpoint in phase 3 trial: high statistical significance in prevention of recurrence of posterior uveitis (pless than 0.00000001). 2015. Available at: http://investors.psivida.com/releasedetail.cfm?ReleaseID=947883. Accessed January 6, 2016.
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Iluvien Implantation for Uveitis and Uveitic Macular Edema

REFERENCES

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Iluvien Implantation for Uveitis and Uveitic Macular Edema

REFERENCES

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date